In a significant milestone for neural engineering and ophthalmology, Science Corporation has unveiled compelling long-term data from...
Treatment Innovations
In a landmark development for the European life sciences sector, Netherlands-based venture capital firm Forbion has successfully...
In the landscape of modern drug discovery, the traditional animal study has long functioned as a linear,...
In the rapidly evolving landscape of neural engineering and ophthalmic restoration, Science Corporation has reached a significant...
The landscape of Type 1 diabetes (T1D) management is undergoing a profound transformation, moving away from fragmented,...
In the high-stakes world of biotechnology, clinical trial results serve as the primary pulse of the industry....
In a significant move aimed at curbing the proliferation of potent, semi-synthetic substances, the U.S. Drug Enforcement...
The medical device landscape is currently navigating a significant regulatory challenge following the recent recall of certain...
By Jonathan Gardner | October 2, 2026 The biotechnology sector is characterized by a binary nature: companies...
For pharmaceutical companies, the journey from a successful Phase III clinical trial to a full-scale commercial launch...
